New answer by Radiation Oncologist at The Ohio State University - James Cancer Hospital and Solove Research Institute (December 12, 2025)
From a non-CNS sarcoma standpoint, there is published European experience with definitive-intent RT for unresected SFT, and a clear dose-response relationship, with ~80% local...